1. Home
  2. ETHZ vs ANGO Comparison

ETHZ vs ANGO Comparison

Compare ETHZ & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETHZ
  • ANGO
  • Stock Information
  • Founded
  • ETHZ N/A
  • ANGO 1988
  • Country
  • ETHZ United States
  • ANGO United States
  • Employees
  • ETHZ N/A
  • ANGO N/A
  • Industry
  • ETHZ Biotechnology: Pharmaceutical Preparations
  • ANGO Medical/Dental Instruments
  • Sector
  • ETHZ Health Care
  • ANGO Health Care
  • Exchange
  • ETHZ Nasdaq
  • ANGO Nasdaq
  • Market Cap
  • ETHZ 465.0M
  • ANGO 400.8M
  • IPO Year
  • ETHZ N/A
  • ANGO 2004
  • Fundamental
  • Price
  • ETHZ $2.31
  • ANGO $10.73
  • Analyst Decision
  • ETHZ
  • ANGO Strong Buy
  • Analyst Count
  • ETHZ 0
  • ANGO 3
  • Target Price
  • ETHZ N/A
  • ANGO $19.00
  • AVG Volume (30 Days)
  • ETHZ 30.2M
  • ANGO 379.9K
  • Earning Date
  • ETHZ 10-26-2025
  • ANGO 10-02-2025
  • Dividend Yield
  • ETHZ N/A
  • ANGO N/A
  • EPS Growth
  • ETHZ N/A
  • ANGO N/A
  • EPS
  • ETHZ N/A
  • ANGO N/A
  • Revenue
  • ETHZ N/A
  • ANGO $292,498,000.00
  • Revenue This Year
  • ETHZ N/A
  • ANGO $7.13
  • Revenue Next Year
  • ETHZ N/A
  • ANGO $6.28
  • P/E Ratio
  • ETHZ N/A
  • ANGO N/A
  • Revenue Growth
  • ETHZ N/A
  • ANGO N/A
  • 52 Week Low
  • ETHZ $0.66
  • ANGO $5.83
  • 52 Week High
  • ETHZ $17.75
  • ANGO $13.50
  • Technical
  • Relative Strength Index (RSI)
  • ETHZ N/A
  • ANGO 77.03
  • Support Level
  • ETHZ N/A
  • ANGO $9.70
  • Resistance Level
  • ETHZ N/A
  • ANGO $9.20
  • Average True Range (ATR)
  • ETHZ 0.00
  • ANGO 0.32
  • MACD
  • ETHZ 0.00
  • ANGO 0.18
  • Stochastic Oscillator
  • ETHZ 0.00
  • ANGO 92.44

About ANGO AngioDynamics Inc.

AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.

Share on Social Networks: